和邦生物涨2.04%，成交额1.59亿元，主力资金净流入227.97万元

Core Viewpoint - The stock of Hebang Biotechnology has shown a positive trend with a year-to-date increase of 10.62%, reflecting investor interest and market activity [1]. Group 1: Stock Performance - As of February 11, the stock price of Hebang Biotechnology reached 2.50 CNY per share, with a trading volume of 1.59 billion CNY and a market capitalization of 22.079 billion CNY [1]. - The stock has experienced a 0.81% increase over the last five trading days, a 14.68% increase over the last 20 days, and a 2.46% increase over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" once this year, with a net buy of 59.5468 million CNY on January 28, accounting for 14.52% of total trading volume [1]. Group 2: Company Overview - Hebang Biotechnology, established on August 1, 2002, and listed on July 31, 2012, is located in Leshan, Sichuan Province, and specializes in the manufacturing of pesticides, fine chemicals, and various glass products [2]. - The company's revenue composition includes 85.89% from chemical products, 17.61% from photovoltaic glass and other products, 6.74% from mineral products, and 5.02% from other businesses [2]. - The company operates within the basic chemical industry, specifically in the agricultural chemical sector, and is involved in concepts such as chemical raw materials and phosphate chemicals [2]. Group 3: Financial Performance - For the period from January to September 2025, Hebang Biotechnology reported a revenue of 5.927 billion CNY, a decrease of 13.02% year-on-year, and a net profit attributable to shareholders of 93.1085 million CNY, down 57.93% year-on-year [2]. - The company has distributed a total of 1.205 billion CNY in dividends since its A-share listing, with 553 million CNY distributed over the past three years [3]. Group 4: Shareholder Information - As of September 30, 2025, the number of shareholders for Hebang Biotechnology was 196,500, a decrease of 1.99% from the previous period, with an average of 44,939 shares held per shareholder, an increase of 2.03% [2]. - Notable institutional shareholders include Penghua CSI Sub-Sector Chemical Industry Theme ETF and Southern CSI 500 ETF, with significant holdings and changes in share quantities [3].